RAC 0.97% $1.54 race oncology ltd

Ann: Race releases complete cardio-protection data & video, page-188

  1. 951 Posts.
    lightbulb Created with Sketch. 227
    On those crazy valuations, no one is going to buy us for $100's a share.

    I assume we would then negotiate favourable royalty payments in lieu of those crazy numbers up front? What's the pro/cons for this?

    Are there any other ways the sale may go?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.